Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$16.94
-$0.17 (-1.0%)
Closing Price on November 13, 2024

TEVA Articles

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Even if a lot of this 10-year bull market was simply playing catch-up from the bottom, it still seems pretty pathetic that some corporate giants have hardly noticed that they were in the midst of the...
The top analyst upgrades, downgrades and initiations seen on Wednesday included CSX, Intelsat, Kohl's, NIO, Rio Tinto, Teva Pharmaceutical, TripAdvisor and VMware.
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations seen on Thursday included CenturyLink, Chimera Investment, Comerica, Dish Networks, Exxon Mobil, NetApp, Pulte, Petrobras, Teva Pharmaceutical and...
Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has reviewed Coca-Cola, Deere and some of the other key companies reporting this coming week.
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer, Tesla, Teva Pharmaceutical and...
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary hyperparathyroidism in adult patients with chronic...
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators...
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.